| PDF (728kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-198729
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.19872
Zusammenfassung
In 36 healthy control subjects (21 females, 15 males; age range 18-65 years; mean age 41.8 years, SD 15.6 years), a bedtime dose of 1.5 mg RS 86, an orally acting cholinergic agonist, shortened rapid eye movement (REM) latency, increased REM sleep, and decreased slow-wave sleep. Six of the subjects (greater than 40 years old) even displayed sleep-onset REM periods after the drug. Results of the ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik